AC
Abraham Ceesay (Chief Executive Officer) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales), most often in Rapport Therapeutics, Inc. (RAPP). The largest single filing was $2.4M of RAPP (51,499 sh across 5 lots, as filed), executed Aug 10. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
8
0 buys · 8 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$4.8M
shares × price, as filed
Last traded
Oct 6
Filed Oct 8
Median ADV $17.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $7.0M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
8 filings
Sector per market data · by filing · past 12 months
Most traded names
RAPPRecent filings
RAPPSALE
Rapport Therapeutics, Inc.
View filing →
$108K3,375 sh × $32.03
Exec Oct 6
Filed Oct 8 · 4:07 PM ET RAPPSALE Rapport Therapeutics, Inc. View filing → $325K
7,141 sh × $45.55
Exec Sep 8
Filed Sep 9 · 4:05 PM ET RAPPSALE Rapport Therapeutics, Inc. View filing → $938K
18,921 sh × $49.57
Exec Aug 25
Filed Aug 26 · 4:05 PM ET RAPPSALE Rapport Therapeutics, Inc. View filing → $2.4M
51,499 sh across 5 lots
Exec Aug 10
Filed Aug 12 · 4:35 PM ET RAPPSALE Rapport Therapeutics, Inc. View filing → $328K
8,210 sh across 2 lots
Exec Jul 14
Filed Jul 15 · 4:15 PM ET RAPPSALE Rapport Therapeutics, Inc. View filing → $292K
7,344 sh × $39.77
Exec Jun 29
Filed Jul 1 · 4:05 PM ET RAPPSALE Rapport Therapeutics, Inc. View filing → $103K
3,552 sh × $29.05
Exec Feb 18
Filed Feb 19 · 5:30 PM ET RAPPSALE Rapport Therapeutics, Inc. View filing → $285K
10,916 sh across 2 lots
Exec Jan 20
Filed Jan 22 · 5:30 PM ET More filings →